[Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma]

Gan To Kagaku Ryoho. 2016 May;43(5):539-44.
[Article in Japanese]
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use*
  • Child
  • Clinical Trials as Topic
  • Humans
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy*
  • Recurrence

Substances

  • Antineoplastic Agents